Anti-Matrilysin
Anti-Matrix Metalloproteinase 7

Host: Mouse

Isotype: IgG2b

Immunogen: recombinant human MMP-7

Form: Liquid

Formulation: In 10 mM PBS, 0.2% BSA, pH 7.4.

Preservative: ≤0.1% sodium azide

Positive Control: Conditioned, serum-free medium from SW620 cells or bladder, breast, or ovarian carcinomas

Comments: Recognizes the ~28 kDa latent and the ~19 kDa active forms of MMP-7 in SW620 cells and bladder, breast, and ovarian carcinoma tissue.

Ref.: Brunner, K.L, et al. 1995. Proc. Natl. Acad. Sci. USA 92, 7362. Imai, K., et al. 1995. J. Biol. Chem. 270, 6691. Lichtinghagen, R., et al. 1995. Eur. J. Clin. Chem. Clin. Biochem. 33, 65. Nakano, A., et al. 1995. J. Neurosurg. 83, 298. Woessner, J.F., Jr. 1995. Meth. Enzymol. 248, 485. Yamamoto, H., et al. 1995. J. Clin. Lab. Anal. 9, 297. Gaire, M., et al. 1994. J. Biol. Chem. 269, 2032. McDonnell, S., et al. 1994. Biochem. Soc. Trans. 22, 58. Cottam, D.W. and Rees, R.C. 1993. Intl. J. Oncol. 2, 861. Stetler-Stevenson, W.G., et al. 1993. FASEB J. 7, 1434. Woessner, J.F. 1991. FASEB J. 5, 2145. Liotta, L.A. and Stetler-Stevenson, W.G. 1990. In Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1, 99. Sellers, A, and Woessner, J.F., Jr. 1980. Biochem. J. 189, 521.

Not available for sale in Japan.